Non-invasive diagnosis and follow-up of rare genetic liver diseases - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Journal Articles Clinics and Research in Hepatology and Gastroenterology Year : 2022

Non-invasive diagnosis and follow-up of rare genetic liver diseases

Abstract

Rare genetic liver diseases can result in multi-systemic damage, which may compromise the patient's prognosis. Wilson's disease and alpha-1 antitrypsin deficiency must be investigated in any patient with unexplained liver disease. Cystic fibrosis screening of new-borns is now implemented in most high-prevalence countries. The diagnosis of these diseases can be strongly suggested with specific non-invasive tests. Molecular analysis gene for these diseases is long and tedious but is recommended to confirm the diagnosis and help for the family screening. Liver biopsy is not systematic and is discussed when it helps diagnosis. Currently, for these three diseases, non-invasive fibrosis markers could identify patients with risk of cirrhosis and complications. Rare genetic liver diseases can result in multi-systemic damage, which may compromise the patient's prognosis. Wilson's disease, must be investigated in any patient with unexplained liver disease and/or unexplained neurological or neuropsychiatric disorders. The diagnosis is based on a combination of clinical, biological features, including copper balance. The exchangeable copper/total copper ratio is a new sensible and specific biological marker, useful for the diagnosis of the disease. Timely diagnosis and treatment will prevent serious complications from the disease. Neurological evaluation and familial screening are essential in patients with Wilson's disease.
Embargoed file
Embargoed file
Visibility date is undetermined

Dates and versions

inserm-03651866 , version 1 (26-04-2022)

Identifiers

Cite

Rodolphe Sobesky, Olivier Guillaud, Charlotte Bouzbib, Philippe Sogni, Aurélia Poujois, et al.. Non-invasive diagnosis and follow-up of rare genetic liver diseases. Clinics and Research in Hepatology and Gastroenterology, 2022, 46 (1), pp.101768. ⟨10.1016/j.clinre.2021.101768⟩. ⟨inserm-03651866⟩
27 View
9 Download

Altmetric

Share

Gmail Facebook X LinkedIn More